ページ内を移動するためのリンクです。

Financial Highlights

*From FY2016, International Financial Reporting Standards (IFRS) is applied.Information for FY2015 is also presented in line with IFRS.

Key Results (Tables)Click to view graphs.

Consolidated Financial Data (JPY billion / % change)

  JGAAP IFRS
FY2013 FY2014※1
(Apr-Dec)
FY2015 FY2016 FY2017
Net Sales 1,452.8 1,224.3 1,427.4 1,195.5 1,240.0
19.3% -16.2% 3.7%
Operating Profit 198.7 196.5 148.9 101.1 104.2
17.1% -32.1% 3.0%
Profit Attributable to Owners of Parent ※2 151.0 143.1 102.0 92.6 112.5
23.3% -9.2% 21.5%
Research and Development
Expenses
249.0 172.9 202.7 168.8 175.6
29.4% -16.7% 4.0%

Notes:

 1. Due to a change in the fiscal year end to December, FY2014, a transitional period for the change, covers nine months from April 1, 2014 to December 31, 2014.
Thus, percentage changes of FY2014 and FY2015 compared to the previous fiscal year are not applicable.

 2. Equivalent to Net Income under J-GAAP (Japanese Generally Accepted Accounting Principles).

  JGAAP IFRS
FY2013 FY2014※1
(Apr-Dec)
FY2015 FY2016 FY2017
Total Assets 2,028.4 2,178.2 2,575.3 2,478.3 2,480.3
Total Equity※3 1,510.8 1,658.6 1,727.4 1,738.4 1,822.0
Ratio of equity attributable to owners of parent to total assets※4 73.2 74.7 66.0 69.0 72.3

 3. Equivalent to Net Assets under J-GAAP.

 4. Equivalent to Shareholders' equity ratio under J-GAAP.

Geographical Segment Sales

  FY2017 (JPY billion) % of Net Sales
Japan 638.7 51.5
North America 318.2 25.7
Others 283.1 22.8
Total 1,240.0 100.0
Sales to customers by market.

Sales by Business Segment

  FY2017 (JPY billion) % of Net Sales
Pharmaceutical business 774.8 62.5
Nutraceutical business 314.7 25.4
Consumer products business 35.3 2.8
Other business 115.2 9.3
Total 1,240.0 100.0
Sales to customers by market.

Key Management Indicators

  JGAAP IFRS
FY2013 FY2014※1
(Apr-Dec)
FY2015 FY2016 FY2017
ROE (%) 10.8% 9.2% 6.1% 5.4% 6.4%
EPS (yen) 278.1 264.2 188.2 170.8 207.6
Annual dividends per share (yen) 65.0 75.0 100.0 100.0 100.0
Payout ratio (%) 23.4% 28.4% 53.1% 58.5% 48.2%

Key Results (Graphs)Click to view tables.

  • Graph:Net Sales

  • Graph:Operating Income

  • Graph:Research and Development Expenditure

  • Graph:Geographical Segment Sales

  • Sales by Business Segment